The ASCI’s 2016 Ballot results

The Active segment of the ASCI membership recently voted on candidates for Council vacancies, on nominees recommended for election this year to the Society, and on a change to the organization’s bylaws. The results were recently audited and confirmed.

The following members will join the Council at the conclusion of the 2016 annual meeting, April 15-17:

Elected to Council

Vice President: Kieren Marr, MD, Associate Vice-Chair of Medicine for Innovation at Johns Hopkins. She was elected in 2009.
Secretary-Treasurer Elect: Hossein Ardehali, MD, PhD, Professor of Medicine-Cardiology and Professor of Pharmacology, Northwestern Medicine. He was elected in 2012.
Councilor: Andrew P. Fontenot, MD, Henry N. Claman Professor of Medicine, University of Colorado Denver. He was elected in 2009.

Elected members, 2016

The Council received 160 membership nominations for 2016 and recommended 74 nominees for election; the recommendation was approved. Those being inducted at the ASCI Dinner and New Member Induction Ceremony on April 15, 2016, are listed below.

Derek W. Abbott, MD, PhD

Case Western Reserve University School of Medicine

Vahid Afshar-Kharghan, MD

University of Texas M.D. Anderson Cancer Center

John H. Alexander, MD, MHSc

Duke University & Duke-NUS Graduate Medical School

Balamurali K. Ambati, MD, PhD, MBA

University of Utah School of Medicine

Joseph R. Arron, MD, PhD

Genentech

Euan A. Ashley, MRCP, DPhil, FACC, FESC

Stanford University School of Medicine

Kamran Atabai, MD

University of California, San Francisco, School of Medicine

Jasmohan S. Bajaj, MBBS, MD, MS

Virginia Commonwealth University School of Medicine

Robert H. Baloh, MD, PhD

Cedars Sinai Medical Center

Sanjay Basu, MD, PhD

Stanford University School of Medicine

Trever Bivona, MD, PhD

University of California, San Francisco, School of Medicine

Catherine A. Blish, MD, PhD

Stanford University School of Medicine

George A. Calin, MD, PhD

University of Texas M.D. Anderson Cancer Center

Stephen Y. Chan, MD, PhD

University of Pittsburgh School of Medicine

John Tzu-yu Chang, MD

University of California, San Diego, School of Medicine

Keith A. Choate, MD, PhD, FAAD

Yale School of Medicine

Hyung J. Chun, MD

Yale School of Medicine

Peter A. Crawford, MD, PhD

Sanford-Burnham Medical Research Institute at Lake Nona

Jeffrey R. Curtis, MD, MS, MPH

University of Alabama at Birmingham School of Medicine

Sandip K. Datta, MD

NIH, National Institute of Allergy and Infectious Diseases

Michael A. Davies, MD, PhD

University of Texas M.D. Anderson Cancer Center

Benjamin Dekel, MD, PhD

The Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center

Wonder Puryear Drake, MD

Vanderbilt University School of Medicine

Ronny I. Drapkin, MD, PhD

University of Pennsylvania School of Medicine

Elia J. Duh, MD

Johns Hopkins University School of Medicine

Margaret Feeney, MD, MMSc

University of California, San Francisco, School of Medicine

Todd A. Fehniger, MD, PhD

Washington University in St. Louis School of Medicine

Christopher Robert Flowers, MD, MS

Emory University School of Medicine

Lawrence B. Gardner, MD

New York University School of Medicine

Rasheed A. Gbadegesin, MBBS, MD

Duke University School of Medicine

William Michael Geisler, MD, MPH

University of Alabama at Birmingham School of Medicine

Pradipta Ghosh, MD

University of California, San Diego, School of Medicine

Hitinder S. Gurm, MBBS

University of Michigan Medical School

Jeffrey P. Henderson, MD, PhD

Washington University in St. Louis School of Medicine

Tobias M. Hohl, MD, PhD

Memorial Sloan Kettering Cancer Center

Melina R. Kibbe, MD

Northwestern University Feinberg School of Medicine

Gregory Dale Kirk, MD, MPH, PhD

Johns Hopkins University School of Medicine

Harriet Margot Kluger, MD

Yale School of Medicine

Bernhard Kühn, MD

University of Pittsburgh Children’s Hospital

Pamela M. Ling, MD, MPH

University of California, San Francisco, School of Medicine

David B. Lombard, MD, PhD

University of Michigan Medical School

Sami N. Malek, MD

University of Michigan Medical School

J. Michael McWilliams, MD, PhD

Harvard Medical School, Brigham & Women’s Hospital

Funda Meric-Bernstam, MD

University of Texas M.D. Anderson Cancer Center

Timothy M. Miller, MD, PhD

Washington University in St. Louis School of Medicine

James K. Min, MD

Weill Cornell Medical College

Andy Minn, MD, PhD

University of Pennsylvania School of Medicine

Goutham Narla, MD, PhD

Case Western Reserve University School of Medicine

Aimee S. Payne, MD, PhD

University of Pennsylvania School of Medicine

Sallie Robey Permar, MD, PhD

Duke University School of Medicine

Andrew Pieper, MD, PhD

University of Iowa Carver College of Medicine

Carla M. Pugh, MD, PhD

University of Wisconsin Medical School

Benjamin Alexander Raby, MD, CM, MPH

Harvard Medical School, Brigham & Women’s Hospital

Soumya Raychaudhuri, MD, PhD

Harvard Medical School, Brigham & Women’s Hospital

Daniel Salo Reich, MD, PhD

NIH, National Institute of Neurological Disorders and Stroke

Caterina Rosano, MD, MPH

University of Pittsburgh School of Public Health

Ivan O. Rosas, MD

Harvard Medical School, Brigham & Women’s Hospital

Bernd Schnabl, MD

University of California, San Diego, School of Medicine

Lecia VanDam Sequist, MD, MPH

Harvard Medical School, Massachusetts General Hospital

Nigam H. Shah, MBBS, PhD

Stanford University School of Medicine

Sunil Singhal, MD

University of Pennsylvania School of Medicine

Agata Smogorzewska, MD, PhD

The Rockefeller University

Justin Stebbing, MA, FRCP, FRCPath, PhD

Imperial College London

Ulrich G. Steidl, MD, PhD

Albert Einstein College of Medicine of Yeshiva University

Helen Chun-Hui Su, MD, PhD

NIH, National Institute of Allergy and Infectious Diseases

Rebecca L. Sudore, MD

University of California, San Francisco, School of Medicine

Stephen H. Tsang, MD, PhD

Columbia University College of Physicians & Surgeons

Jack W. Tsao, MD, DPhil

University of Tennessee Health Science Center

David Tuveson, MD, PhD

Cold Spring Harbor Laboratory

Conrad Christian Weihl, MD, PhD

Washington University in St. Louis School of Medicine

Juan Pablo Wisnivesky, MD, DrPH

Icahn School of Medicine at Mount Sinai

Sean M. Wu, MD, PhD, FACC

Stanford University School of Medicine

Koji Yasutomo, MD, PhD

Tokushima University

Manuel Yepes, MD

Emory University School of Medicine

The ASCI’s 2016 Young Physician-Scientist Awards

The ASCI congratulates the 40 recipients of its 2016 Young Physician-Scientist Awards, who will be recognized at the 2016 AAP/ASCI/APSA Joint Meeting and present their work on April 16, 2016.

Awardee Institution
Dennis M. Abraham, MD Duke University Medical Center
Brian C. Belyea, MD University of Virginia, School of Medicine
Evan L. Brittain, MD, MSc Vanderbilt University
Timothy F. Burns, MD, PhD University of Pittsburgh
Jaehyuk Choi, MD, PhD Northwestern University School of Medicine
Jane Churpek, MD The University of Chicago
Janet L. Crane, MD Johns Hopkins University
Vinicio de Jesus Perez, MD Stanford University School of Medicine
Shadmehr (Shawn) Demehri, MD, PhD Massachusetts General Hospital, Harvard Medical School
Michelle R. Denburg, MD, MSCE The Children’s Hospital of Philadelphia
Elizabeth S. Egan, MD, PhD Stanford University School of Medicine
Sascha N. Goonewardena, MD University of Michigan
Andrew Caleb Hsieh, MD Fred Hutchinson Cancer Research Center
Yvonne Jean Huang, MD University of Michigan
Marcin Imielinski, MD, PhD Weill Cornell Medicine
Ravi Karra, MD, MHS Duke University
Hamed Khalili, MD, MPH Massachusetts General Hospital
Mark E. Kleinman, MD University of Kentucky
Birgit Knoechel, MD PhD Dana-Farber Cancer Institute
George Boateng Kyei, MB, ChB, PhD Washington University School of Medicine
Dan A. Landau, MD, PhD Weill Cornell Medicine
Edward B. Lee, MD, PhD University of Pennsylvania
James Lo, MD, PhD Weill Cornell Medical College
Alexander Marson, MD, PhD University of California, San Francisco
Shana E. McCormack, MD The Children’s Hospital of Philadelphia
Peggy Suejin Myung, MD, PhD Yale University
Ian J. Neeland, MD UT Southwestern Medical Center
Alexis Ogdie, MD, MSCE University of Pennsylvania
Tien Peng, MD University of California, San Francisco
Rithwick Rajagopal, MD, PhD Washington University School of Medicine
Tamer Sallam, MD, PhD University of California, Los Angeles
Amy Sanghavi Shah, MD, MS Cincinnati Children’s Hospital Medical Center
Ravi Shah, MD Beth Israel Deaconess Medical Center
Raymond E. Soccio, MD, PhD Perelman School of Medicine at University of Pennsylvania
Roderick J. Tan, MD, PhD University of Pittsburgh
Gregory Edward Tasian, MD, MSc, MSCE The Children’s Hospital of Philadelphia
David T. Ting, MD Massachusetts General Hospital Cancer Center
Christina Twyman-Saint Victor, MD University of Pennsylvania
Nikhil Wagle, MD Dana-Farber Cancer Institute
Elaine Wan, MD, FACC, FAHA Columbia University

Recipient of the 2016 Seldin~Smith Award: Christian P. Schaaf, MD, PhD

 

Christian Schaaf

The American Society for Clinical Investigation (ASCI) is pleased to announce that Christian P. Schaaf, MD, PhD, is the recipient of its inaugural Donald Seldin~Holly Smith Award for Pioneering Research. Dr. Schaaf is an Assistant Professor in the Department of Molecular and Human Genetics at Baylor College of Medicine and Investigator at the Texas Children’s Hospital’s Jan and Dan Duncan Neurological Research Institute.

Dr. Schaaf’s research focuses on understanding the genetic and molecular basis of human cognitive and behavioral disorders. The starting point of his work is always a patient or a family. After identifying the causative genetic defect, he performs deep and rigorous scientific inquiry. Two syndromes carry his name: Schaaf-Yang syndrome, which is characterized by intellectual disability, low muscle tone, feeding problems, and joint contractures; and Bosch-Boonstra-Schaaf optic atrophy syndrome, where patients have delayed development, intellectual disability, and atrophy of optic nerves, resulting in vision impairment. Subsequent to his genetic discoveries, others with these two syndromes have since been identified, and they are now being evaluated with an improved understanding of their conditions.

In the best tradition of the ASCI, Dr. Schaaf is a triple threat: a physician, a scientist, and an educator. “The degree to which I’ve been successful and fulfilled in the work that I do is due to the fact that I’m doing all three of these things,” he said. Dr. Huda Zoghbi, director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and mentor at Baylor College of Medicine, supported Dr. Schaaf’s nomination. “Christian doesn’t give up easily, and he has solved numerous medical mystery cases, empowering patients and their families by providing them an accurate diagnosis,” she wrote in her letter accompanying his nomination. “He embodies all of the best qualities of a caring physician and rigorous scientist.”

Development of the Seldin~Smith Award began several years ago with the goal of connecting the legacies of two heroes of the physician-scientist community with exceptionally creative early-career physician-scientists. These heroes are Donald Seldin (University of Texas Southwestern Medical Center) and Lloyd “Holly” Smith Jr. (University of California, San Francisco). The Seldin~Smith Award, now with its first honoree, complements the prestigious Stanley J. Korsmeyer Award from the ASCI, which recognizes senior physician-scientists who have made major contributions to science and mentorship. The ASCI is grateful to Drs. Seldin and Smith, who provided the inspiration for this Award through their storied careers of developing generations of outstanding physician-scientists.

Dr. Schaaf was selected from a group of highly qualified nominees in the United States and abroad. The applicants were evaluated by a Selection Committee of current and former ASCI leaders: Mukesh K. Jain and Vivian G. Cheung (Co-Chairs), Charles L. Sawyers, Elizabeth M. McNally, and Stuart H. Orkin. Finalists were evaluated by an Advisory Committee comprising five physician-scientist luminaries: Joseph L. Goldstein (Chair), Michael S. Brown, Arthur Weiss, Stanley B. Prusiner, and Robert J. Lefkowitz. The ASCI will provide Dr. Schaaf with an unrestricted award of $30,000 to advance his academic efforts, and the leadership of the ASCI will recognize Dr. Schaaf at its 2016 annual meeting, April 15-17, in Chicago. Dr. Schaaf will deliver a scientific talk at the ASCI’s 2017 annual meeting.

About the ASCI: Founded in 1908, the American Society for Clinical Investigation is one of the oldest and most esteemed nonprofit honor societies of physician-scientists. Membership is by election only, and only researchers who are 50 years of age or younger are eligible for nomination. Therefore, membership in the ASCI recognizes a researcher’s significant contributions, at a relatively young age, to the understanding of human disease. The Society counts among its ranks almost 3,000 members, many of whom are leaders in academic medicine and industry. Many members have been recognized by election to the U.S. National Academy of Sciences and the U.S. National Academy of Medicine. The ASCI is also proud to have among its membership winners of the Nobel Prize and the Lasker Award. The Society self-publishes the prestigious Journal of Clinical Investigation, a top-tier biomedical journal, and JCI Insight, launched in late 2015. The ASCI holds its annual meeting with the Association of American Physicians and the American Physician-Scientists Association.

The 2016 Harrington Prize for Innovation in Medicine: Jeffrey M. Friedman, MD, PhD

Harrington Discovery Institute and The American Society for Clinical Investigation honor Jeffrey M. Friedman, MD, PhD

Dr. Friedman

The third annual Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, of The Rockefeller University, New York City, for his discovery of leptin and the leptin-mediated pathway that controls feeding behavior.

The Harrington Prize for Innovation in Medicine, established in 2014 by the Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio and The American Society for Clinical Investigation (ASCI), honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and potential for clinical application.

Dr. Friedman’s discovery of leptin and the neural pathway that leptin mediates revealed the underlying mechanism of what drives feeding behavior in mice and humans. Of particular note, his discovery provided a foundation for deeper understanding of related pathologies, such as obesity – a major public-health problem at the time of this discovery in 1994 and persists around the world today.

“His truly remarkable work has been instrumental to understanding how our bodies regulate weight and what causes obesity,” Marc Tessier-Lavigne, PhD, President of The Rockefeller University, said of Dr. Friedman. “Jeff is a leader in his field and an exemplary Rockefeller scientist whose transformative research sets a high bar that inspires colleagues, friends, and students within our community and around the world.”

“Dr. Friedman’s translational research serves as the foundation for what we know today about some of the biological factors contributing to obesity,” said Levi A. Garraway, MD, PhD, Associate Professor, Medicine, Harvard Medical School, and current President of the ASCI. “This is precisely the type of research breakthrough that the Harrington Prize seeks to recognize for its impact on our understanding of the human body and how we care for it.”

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed 30 nominations from 25 institutions and five countries before selecting Dr. Friedman as the recipient.

“We are pleased to join with the ASCI to honor Dr. Friedman and his team’s contributions to medicine,” said Jonathan Stamler, MD, Director of the Harrington Discovery Institute and the Robert S. and Sylvia K. Reitman Distinguished Chair in Cardiovascular Innovation at UH Case Medical Center and Case Western Reserve University School of Medicine. “The Harrington Discovery Institute is creating a network of the best and brightest physician-scientists from across the country and around the world, who are impacting the future of medicine. Together with ASCI, the Harrington Discovery Institute recognizes one of the true giants in our community.”

In addition to receiving a $20,000 honorarium, Dr. Friedman will deliver The Harrington Prize Lecture at the 2016 ASCI and Association of American Physicians Joint Meeting on April 15, and publish an essay in The Journal of Clinical Investigation.

Dr. Friedman received his MD from Albany Medical College in 1977 and his PhD from The Rockefeller University in 1984. He is the Marilyn M. Simpson Professor at The Rockfeller University and has been an Investigator of the Howard Hughes Medical Institute since 1996.

He is an elected member to the prestigious National Academy of Sciences and is recipient of numerous awards and honors including the Albert Lasker Basic Medical Research Award, the Shaw Prize for Life Sciences and Medicine, and the King Faisal International Prize in Medicine.

The first recipient of the Harrington Prize for Innovation in Medicine, in 2014, was Dr. Harry Dietz, a pediatric cardiologist and genetics researcher from Johns Hopkins University School of Medicine. The Prize recognized Dr. Dietz’s contributions to the understanding of biology and treatment of aortic aneurysms and other connective tissue disorders. The 2015 Prize recipient was Douglas R. Lowy, MD, Chief, Laboratory of Cellular Oncology, and Acting Director of the National Cancer Institute, in recognition of his discoveries that led to the development of the Human Papillomavirus (HPV) vaccine to prevent cervical cancer.

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation’s oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.

# # #

Harrington Discovery Institute

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio—part of The Harrington Project for Discovery & Development—aims to advance medicine and society by enabling our nation’s most inventive physician-scientists to turn their discoveries into medicines that improve human health.

The Harrington Project for Discovery & Development

The Harrington Project for Discovery & Development (The Harrington Project), announced in late February 2012, is a first-of-its-kind $250 million national initiative, powered by a $50 million gift from the Harrington family. It includes the Harrington Discovery Institute and BioMotiv, a for-profit, mission- aligned development company that oversees a portfolio of early-stage programs, which are built to be licensed to pharmaceutical companies. For more information about The Harrington Project, the Harrington Discovery Institute and The Harrington Prize for Innovation in Medicine, visit: www.HarringtonDiscovery.org

About University Hospitals

Founded in May 1866, University Hospitals serves the needs of patients through an integrated network of 18 hospitals, more than 40 outpatient health centers and primary care physician offices in 15 counties throughout Northeast Ohio. At the core of our $4 billion health system is University Hospitals Case Medical Center, ranked among America’s best hospitals by U.S. News & World Report. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women’s health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women’s Hospital, Ohio’s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. UH is the second largest employer in Northeast Ohio with 26,000 employees. For more information, go to www.UHhospitals.org.

The 2016 Stanley J. Korsmeyer Award: Jean-Laurent Casanova, MD, PhD

Jean-Laurent Casanova
Credit: Mario Morgado

Jean-Laurent Casanova, MD, PhD, is the recipient of the 2016 American Society for Clinical Investigation (ASCI) Stanley J. Korsmeyer Award in recognition for his discovery that single-gene inborn errors of immunity can underlie life-threatening infectious diseases in otherwise healthy children and young adults.

From the 1950s onward, studies in the field of primary immunodeficiency showed that rare mutations in a single host defense gene may confer Mendelian inheritance of both an overt immunological phenotype and a peculiar infectious phenotype, with susceptibility to multiple, recurrent, and opportunistic infections. Since the mid-1990s, Dr. Casanova has been testing the hypothesis that severe infectious diseases of otherwise healthy children may result from collections of rare single-gene inborn errors of immunity. His research has transformed understanding of the molecular and cellular basis of susceptibility to many types of infectious diseases in children.

Dr. Casanova’s laboratory is located at the Rockefeller University in New York and at the Necker Hospital for Sick Children in Paris. He leads the experimental branch of the Laboratory of Human Genetics of Infectious Diseases. In collaboration with Dr. Laurent Abel and others, Dr. Casanova has deciphered the molecular genetic basis of infectious diseases caused by various bacteria (such as mycobacterial and pneumococcal diseases), viruses (herpes simplex encephalitis, Kaposi sarcoma, and severe influenza), and fungi (chronic mucocutaneous candidiasis and invasive dermatophytic disease). The findings have had clinical implications by providing a basis for genetic counseling and pointing to potential therapies that may restore certain host factors needed to fight infectious diseases in these patients.

Dr. Casanova received his MD in 1987 from Paris Descartes University, and completed his pediatric residency in 1995 and pediatric hematology-immunology fellowship in 1999 at the Necker Hospital for Sick Children and Paris Descartes University. Dr. Casanova also received a PhD in immunology from Pierre et Marie Curie University in 1992. In 1999, he became Professor of Pediatrics at the Necker Hospital and Paris Descartes University, where he is currently a Visiting Professor. He joined the Rockefeller University as a Professor in 2008 and was named an investigator of the Howard Hughes Medical Institute in 2014.

Dr. Casanova was elected to the American Society for Clinical Investigation in 2008, the National Academy of Sciences in 2015, and the National Academy of Medicine in 2015. He is a recipient of several prestigious international awards, including the InBev-Baillet Latour Health Prize (Belgium) in 2011 and the Robert Koch Award (Germany) in 2014.

Related

Jean-Laurent Casanova honored with the 2016 ASCI/Stanley J. Korsmeyer Award in the Journal of Clinical Investigation

Call for nominations, 2016 Seldin~Smith Award

The ASCI is pleased to announce the Donald Seldin~Holly Smith Award for Pioneering Research. The Award seeks to recognize and connect the next generation of physician-scientist leaders with the legacies of two of the ASCI’s most esteemed members, Drs. Donald W. Seldin and Lloyd H. “Holly” Smith.

For the inaugural Seldin~Smith Award, the ASCI seeks nominations of outstanding physician-scientists who have demonstrated exceptional creativity and accomplishments in biomedical research. The ideal nominee:

  • is an early-stage, clinically active physician-scientist addressing fundamental questions that relate to human health and disease, and
  • shows great promise in biomedicine.

The recipient of the Seldin~Smith Award will receive an unrestricted grant of $30,000 to advance academic efforts. S/he will deliver a research talk at the 2017 ASCI/AAP Joint Meeting and receive mentoring from the members of the Seldin~Smith Award Selection Committee and Advisory Committee.

Eligibility

  • MD (or the equivalent) or MD/PhD;
  • The candidate should be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment at the time of acceptance in April 2016;
  • The candidate spends substantial time in research while providing direct patient care.

This competition is not restricted to any geographic location.

Application

Physician-scientists should apply directly by sending nominations by email attachments to staff@the-asci.org.

  • Completed nomination form, including:
    • a summary of the nominee’s research (not to exceed 100 words)
    • A description of the nominee’s most significant achievement (not to exceed 500 words).
    • a list of the nominee’s three most significant publications and a short statement describing the significance of each publication (not to exceed 100 words each).
    • Nominee’s agreement, if chosen as the recipient, to attend the 2016 ASCI/AAP Joint Meeting (April 15-17) and the 2017 ASCI/AAP Joint Meeting (April 21-23).
  • PDFs of the nominee’s three most significant publications as listed in the nomination form.
  • Nominee’s curriculum vitae. Include only educational background, major awards, and peer-reviewed publications (do not include abstracts, grants, or meeting presentations).
  • No more than two letters of support (as PDFs), one from the nominee’s primary mentor, the other ideally from an individual who is a recognized expert on the subject of the nominee’s research.

Notable dates and selection process

  • Nomination deadline: October 15, 2015.
  • Recipient will be notified by early 2016.
  • Recipient will be recognized at the 2016 ASCI/AAP Joint Meeting, April 15-17.
  • Recipient will deliver a research talk at the 2017 ASCI/AAP Joint Meeting, April 21-23.

The Seldin~Smith Award Selection Committee reviews nominations and selects finalists for further consideration. Members are: Mukesh K. Jain, Vivian G. Cheung, Elizabeth M. McNally, Stuart H. Orkin, and Charles L. Sawyers. Finalists are reviewed by the Seldin~Smith Award Advisory Committee members: Joseph L. Goldstein, Michael S. Brown, Arthur Weiss, Stanley B. Prusiner, and Robert J. Lefkowitz.

About the ASCI

Founded in 1908, the ASCI is home to physician-scientist leaders in academic medicine and industry across the world. The ASCI seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve human health. The Society, based in the United States, is a nonprofit 501(c)(3) organization.

The ASCI’s 2015 Young Physician-Scientist Awards

The ASCI congratulates the 40 recipients of its 2015 Young Physician-Scientist Award recipients, who were recognized at the 2015 ASCI/AAP Joint Meeting and presented their work on April 25, 2015.

Recipient Institution
Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center
Oren Becher, MD Duke University
Eugenio Cingolani, MD Cedars-Sinai Heart Institute
Oscar Colegio, MD, PhD Yale University
Ype P. de Jong, MD, PhD Weill Cornell Medical College
Patricia C. Fulkerson, MD, PhD Cincinnati Children’s Hospital Medical Center
J. Travis Hinson, MD Brigham and Women’s Hospital & Harvard Medical School
Rajan Jain, MD Perelman School of Medicine at the University of Pennsylvania
Peng Ji, MD, PhD Northwestern University
J. Michelle Kahlenberg, MD, PhD University of Michigan Health System
Alex Kentsis, MD, PhD Memorial Sloan Kettering Cancer Center
Jeffery Klco, MD, PhD St. Jude Children’s Research Hospital
Jason S. Knight, MD University of Michigan Health System
Andrew Lane, MD, PhD Dana-Farber Cancer Institute
Steven A. Lubitz, MD, MPH Massachusetts General Hospital
Meena Madhur, MD, PhD Vanderbilt
Sandeep Mallipattu, MD Stony Brook University – State University of New York
Michael Mansour, MD, PhD Massachusetts General Hospital
Bradley A. Maron, MD Brigham and Women’s Hospital – Harvard Medical School
Marcela Maus, MD, PhD University of Pennsylvania
Luc GT Morris, MD, MSc Memorial Sloan Kettering Cancer Center
Nima Mosammaparast, MD, PhD Washington University School of Medicine
Lalitha Nayak, MD Case Western Reserve University
Jesse Nussbaum, MD University of California, San Francisco
Edward D. Plowey, MD, PhD Stanford University School of Medicine
Neil Romberg, MD Yale University
Robert E. Schwartz, MD, PhD Weill Cornell Medical College
Akrit Sodhi, MD, PhD Johns Hopkins University School of Medicine
Edda Spiekerkoetter, MD Stanford University
Matthew L. Steinhauser, MD Brigham and Women’s Hospital Division of Genetics / Harvard Medical School
Nathan Stitziel, MD, PhD Washington University
Amir Tirosh MD PhD Brigham and Women’s Hospital/Harvard Medical School
Keila Torres, MD, PhD UT MD Anderson Cancer Center
Anne-Catrin Uhlemann, MD, PhD Columbia University Medical Center
Kevin C. Wang, MD, PhD Stanford University School of Medicine
Richard Wang, MD, PhD UT Southwestern Medical Center at Dallas
Nathaniel Weathington, MD, PhD University of Pittsburgh
Jennifer Woyach, MD The Ohio State University
Robert Yeh, MD, MSc Massachusetts General Hospital
Hao Zhu, MD Children’s Research Institute at UT Southwestern

The ASCI’s 2015 ballot results

The Active segment of the ASCI membership recently voted on candidates for Council vacancies, on nominees recommended for election this year to the Society, and on a change to the organization’s bylaws. The results were recently audited and confirmed.

 

The following members will join the Council at the conclusion of the 2015 ASCI/AAP Joint Meeting:
  • Vice President: Benjamin L. Ebert, M.D., Ph.D., Associate Professor of Medicine, Harvard Medical School. He was elected in 2011.
  • Councilor: Jay D. Horton, M.D., The Dr. Robert C. and Veronica Atkins Chair in Obesity & Diabetes Research, UT Southwestern Medical Center. He was elected in 2003.
  • Councilor: Clara Abraham, M.D., Associate Professor of Medicine, Yale University School of Medicine. She was elected in 2014.
The Council received 188 membership nominations for 2015 and recommended 75 nominees for election; the recommendation was approved. Those being inducted at the ASCI Dinner and New Member Induction Ceremony on April 24, 2015, are listed below.

 

Last, voters approved a revision to the bylaws to shorten the selection timeline of the Editor of the Journal of Clinical Investigation and to coordinate selection with the ASCI’s annual meeting. Changes to the bylaws require a 75% affirmative vote and at least 40% of Active members must have voted; 59% of Active members voted, and 92% of the voters approved the revision.

Elected members, 2015

Aghi, Manish K.

University of California, San Francisco, School of Medicine
Amaravadi, Ravi Kumar

University of Pennsylvania School of Medicine
Anolik, Jennifer Howitt

University of Rochester School of Medicine & Dentistry
Arias, Cesar A.

University of Texas Medical School at Houston
Bangalore, Sripal

New York University School of Medicine
Bennett-Guerrero, Elliott

Duke University Medical Center
Benzing, Thomas

University of Cologne
Bernstein, Bradley E.

Harvard Medical School, Massachusetts General Hospital
Blelloch, Robert

University of California, San Francisco, School of Medicine
Bottini, Nunzio

La Jolla Institute for Allergy & Immunology
Brentjens, Renier Joseph

Memorial Sloan-Kettering Cancer Center
Chugh, Sumeet S.

Cedars Sinai Medical Center
Chung, Wendy K.

Columbia University College of Physicians & Surgeons
Daldrup-Link, Heike Elisabeth

Stanford University School of Medicine
de Lemos, James A.

University of Texas Southwestern Medical Center
DeMatteo, Ronald P.

Memorial Sloan-Kettering Cancer Center
Fearon, William F.

Stanford University School of Medicine
Fessler, Michael Brian

National Institutes of Health
Fitzgerald, Daniel W.

Weill Cornell Medical College
Fon, Edward A.

Montreal Neurological Institute and Hospital, McGill University
Fong, Lawrence

University of California, San Francisco, School of Medicine
Frank, Natasha Y.

Harvard Medical School, Brigham & Women’s Hospital
Gazzaley, Adam

University of California, San Francisco, School of Medicine
Gottschalk, Stephen Max Gerhard

Baylor College of Medicine
Graham, Douglas K

University of Colorado School of Medicine
Guo, Ming

University of California, Los Angeles, David Geffen School of Medicine
Guttman-Yassky, Emma

Mount Sinai School of Medicine
Halpern, Scott D.

University of Pennsylvania School of Medicine
Hershman, Dawn L.

Columbia University College of Physicians & Surgeons
Hunninghake, Gary Matthew

Harvard Medical School, Brigham & Women’s Hospital
Iacobuzio-Donahue, Christine A.

Memorial Sloan-Kettering Cancer Center
Ix, Joachim H.

University of California, San Diego, School of Medicine
Kahn, Jeremy M.

University of Pittsburgh School of Medicine
Kalinski, Pawel

University of Pittsburgh Medical Center
Kaplitt, Michael G.

Weill Cornell Medical College
Kaufmann, Daniel E.

University de Montreal Faculty of Medicine
Kimmelman, Alec C.

Harvard Medical School, Dana-Farber Cancer Institute
Kumanogoh, Atsushi

Osaka University
Lazaridis, Konstantinos N.

Mayo Clinic
Le, Lu Q.

University of Texas Southwestern Medical Center
Lee, Vivian S.

University of Utah School of Medicine
Lichterfeld, Mathias

Harvard Medical School, Massachusetts General Hospital
Lipkin, Steven M.

Weill Cornell Medical College
Luznik, Leo

Johns Hopkins University School of Medicine
Mempel, Thorsten R.

Harvard Medical School, Massachusetts General Hospital
Nadeau, Kari C.

Stanford University School of Medicine
Nallamothu, Brahmajee K.

University of Michigan Medical School
Noble, Suzanne M.

University of California, San Francisco, School of Medicine
Nobrega, Marcelo A.

University of Chicago Pritzker School of Medicine
Peti-Peterdi, Janos

University of Southern California Keck School of Medicine
Post, Wendy S.

Johns Hopkins University School of Medicine
Rajagopal, Jayaraj

Harvard Medical School, Massachusetts General Hospital
Rajagopalan, Sanjay

University of Maryland School of Medicine
Ram, Sanjay

University of Massachusetts Medical School
Rhee, Kyu Y.

Weill Cornell Medical College
Rowe, Steven Mark

University of Alabama at Birmingham School of Medicine
Sadek, Hesham A.

University of Texas Southwestern Medical Center
Seki, Ekihiro

University of California, San Diego, School of Medicine
Shivkumar, Kalyanam

University of California, Los Angeles, David Geffen School of Medicine
Smith, David M.

University of California, San Diego, School of Medicine
Steinbach, William

Duke University School of Medicine
Stoltz, David A.

University of Iowa Carver College of Medicine
Stuart, Lynda Maria

Bill and Melinda Gates Foundation
Tavazoie, Sohail F.

Rockefeller University
Temel, Jennifer G.

Harvard Medical School, Massachusetts General Hospital
Tewari, Muneesh

University of Michigan Medical School
Velculescu, Victor E.

Johns Hopkins University School of Medicine
Verma, Amit K.

Albert Einstein College of Medicine of Yeshiva University
Verstovsek, Srdan

University of Texas M.D. Anderson Cancer Center
Wagner, Kathryn R.

Johns Hopkins University School of Medicine
Williams, Christopher S.

Vanderbilt University School of Medicine
Winkelmayer, Wolfgang C.

Baylor College of Medicine
Woo, Minna

University of Toronto Faculty of Medicine
Yeh, Jen Jen

University of North Carolina at Chapel Hill
Zaoutis, Theoklis E.

University of Pennsylvania School of Medicine

The 2015 Harrington Prize for Innovation in Medicine: Douglas R. Lowy, MD

Harrington Discovery Institute and The American Society for Clinical Investigation honor National Cancer Institute’s researcher Douglas R. Lowy, MD

The second annual Harrington Prize for Innovation in Medicine has been awarded to oncologist and researcher Douglas R. Lowy, MD, Chief, Laboratory of Cellular Oncology, and Deputy Director of the National Cancer Institute.

The Harrington Prize for Innovation in Medicine, established in 2014 by the Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio and The American Society for Clinical Investigation (ASCI), honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and potential for clinical application.

Dr. Lowy is being recognized for his key discoveries that led to development of the human papillomavirus (HPV) vaccine to prevent cancer. The vaccine developed by Dr. Lowy (in collaboration with Merck and GlaxoSmithKline), and approved by the FDA in 2006, was the first licensed vaccine to prevent cancer by guarding against the sexually transmitted infection that causes the disease. It is estimated that the HPV vaccine can afford close to 100% protection and thus Dr. Lowy’s research has the potential to prevent virtually all of the many cancers caused by HPV.

It is estimated that one out of every six cancers worldwide is caused by infection, with HPV leading to more cancers than any other virus. Infection by HPV causes virtually all cervical cancers, the third deadliest cancer in women worldwide, as well as a high percentage of vaginal, oropharyngeal and other cancers.

“I can’t think of anyone more deserving than Doug Lowy to receive The Harrington Prize for Innovation in Medicine,” said Francis S. Collins, MD, PhD, Director of the National Institutes of Health (NIH). “Through his leadership in the development of the HPV vaccine, Doug has made profound contributions to the prevention of cervical cancer. He continues to seek ways to reduce the burden of this disease in developing countries.”

“Dr. Lowy is an exemplary physician-scientist. His research with former trainee John Schiller helped to identify key aspects of the biology of HPV that guided development and ultimately FDA approval for a vaccine that has significantly improved human health globally,” said Mukesh K. Jain, MD, Scientific Director of the Harrington Discovery Institute and current President of the ASCI.

A committee composed of members of the ASCI Council and the Harrington Discovery Institute Scientific Advisory Board reviewed more than 60 nominations from eight countries before selecting Dr. Lowy as the recipient.

“We are pleased to join with the ASCI to honor Dr. Lowy and his team’s remarkable contribution to medicine,” said Jonathan Stamler, MD, Director of the Harrington Discovery Institute and the Robert S. and Sylvia K. Reitman Distinguished Chair in Cardiovascular Innovation at UH Case Medical Center and Case Western Reserve University School of Medicine. “Dr. Lowy has made a difference and thus serves as a role model for all of us hoping to see our discoveries advanced into medicines that impact the lives of our patients.”

In addition to receiving a $20,000 honorarium, Dr. Lowy will deliver the Harrington Prize Lecture at the 2015 ASCI and Association of American Physicians Joint Meeting on April 24, and publish a review in the April issue of Journal of Clinical Investigation.

Dr. Lowy received his M.D. from New York University School of Medicine. Between 1970 and 1973, he was a research associate in the Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, NIH. He trained in internal medicine at Stanford University and dermatology at Yale University, and started his laboratory at the NCI in 1975.

In addition to his own research, Dr. Lowy is a leader in promoting public health issues related to HPV-associated diseases, especially cervical cancer in developing nations. He is an effective advocate for sustainable comprehensive cervical cancer control in the developing world.

He is an elected member to the prestigious National Academy of Sciences and is recipient of numerous awards and honors including the National Medal of Technology and Innovation from President Obama in 2014. Dr. Lowy has or currently serves as a member of many scientific editorial boards, advisory boards and grant committees.

The first recipient of the Harrington Prize for Innovation in Medicine was Dr. Harry Dietz, a pediatric cardiologist and genetics researcher from Johns Hopkins University School of Medicine. The Prize recognized Dr. Dietz’s contributions to the understanding of biology and treatment of aortic aneurysms and other connective tissue disorders.

The American Society for Clinical Investigation (ASCI), established in 1908, is one of the nation’s oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.

The Harrington Discovery Institute, part of a national initiative unveiled in February 2012 called The Harrington Project for Discovery & Development, is a nonprofit medical institute dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. The Harrington Project is fueled by $250 million in donations and other funding, including $50 million from the Harrington Family.

About University Hospitals
University Hospitals, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 29 outpatient health centers and primary care physician offices in 15 counties. At the core of our $3.5 billion health system is University Hospitals Case Medical Center, ranked among America’s 50 best hospitals by U.S. News & World Report in all 12 methodology-ranked specialties. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation, including cancer, pediatrics, women’s health, orthopaedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women’s Hospital, Ohio’s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to www.uhhospitals.org

The 2015 Stanley J. Korsmeyer Award: Louis J. Ptáček, MD

Louis J. Ptáček, MD, is the 2015 recipient of the American Society for Clinical Investigation’s Stanley J. Korsmeyer Award for research leading to the development of the field of ion channel defects, known commonly as channelopathies.

During his time as a neurology resident at the University of Utah, Dr. Ptáček became interested in epilepsy and migraine because they are episodic in nature and very common. He also encountered a patient who, along with other members of her family, experienced temporary paralysis after physical exertion. He proposed this disease (and others like it) to be a good model for the abnormal electrical excitability in seizure and headache: compared with migraine and epilepsy, this muscle disease has a simpler and strongly genetic phenotype. In the early 1990s, he identified a mutation in a gene that caused abnormal electrical signaling and dysfunctional muscle contraction. Specifically, the defective gene encodes channels in the walls of muscle cells failing to properly transport sodium ions. Dr. Ptáček has since identified genes that produce the ion channel defects behind many related inherited muscle diseases, cardiac arrhythmias, and other disorders.

More recently, Dr. Ptáček and collaborators were the first to identify genes in humans responsible for regulating the circadian rhythm and sleep systems. This work has opened avenues to improved understanding of the similarity between the internal clocks of humans and other organisms, and has allowed investigation into the potential relationship between circadian system pathologies and those present in channelopathies.

Dr. Ptáček received his MD from the University of Wisconsin, Madison, in 1986, and completed his residency in neurology at the University of Utah in 1990. Afterward, he performed postdoctoral studies in human genetics at the University of Utah. Dr. Ptáček currently holds the John C. Coleman Distinguished Professorship in the Department of Neurology at the University of California, San Francisco, where he is also Director of the Neurogenetics Program. He has been a Howard Hughes Medical Institute Investigator since 1997.

Dr. Ptáček was elected to the ASCI in 2000, to the Institute of Medicine in 2007, to the Association of American Physicians in 2009, and to the National Academy of Sciences in 2012.

Related

Louis Ptáček receives the 2015 ASCI/Stanley J. Korsmeyer Award in the Journal of Clinical Investigation